Allen S. Goldey, D.d.s., P.a. in Albion, ME - Dentist

Allen S. Goldey, D.d.s., P.a. is a dental clinic (Dentist) in Albion, Maine. The current practice location for Allen S. Goldey, D.d.s., P.a. is 7 School St, Suite 2, Albion, Maine. For appointments, you can reach them via phone at (207) 437-2100. The mailing address for Allen S. Goldey, D.d.s., P.a. is Po Box 125, Albion, Maine and phone number is () -.

Allen S. Goldey, D.d.s., P.a. is licensed to practice in Maine (license number 3700) and its NPI number is 1023130663. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (207) 437-2100.

Contact Information

	Allen S. Goldey, D.d.s., P.a.
	7 School St Suite 2 Albion ME 04910-6501
	(207) 437-2100
	Not Available

Dental Care Clinic Profile

Full Name	Allen S. Goldey, D.d.s., P.a.
Speciality	Dentist
Location	7 School St, Albion, Maine
Authorized Official Name and Position	Allen Scott Goldey (PRESIDENT)
Authorized Official Contact	2076221919
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Allen S. Goldey, D.d.s., P.a. Po Box 125 Albion ME 04910-0125 Ph: () -	Allen S. Goldey, D.d.s., P.a. 7 School St Suite 2 Albion ME 04910-6501 Ph: (207) 437-2100

NPI Details:

NPI Number	1023130663
Provider Enumeration Date	04/04/2007
Last Update Date	08/22/2020

Medical Identifiers

Medical identifiers for Allen S. Goldey, D.d.s., P.a. such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1023130663	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
122300000X	Dentist	3700 (Maine)	Primary

News Archive

Feeding preterm infants in response to hunger and satiation cues may allow earlier hospital discharge

Although many parents and health care providers attempt to schedule a preterm newborn's feeding pattern, a new review of studies reveals that feeding in response to the infant's own hunger cues might result in earlier discharge from the hospital.

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis announced today that the US Food and Drug Administration has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes.

Scientists identify specific enzymes that make meningitis hard to fight

Two enzymes in meningitis bacteria which prevent the body from successfully fighting off the disease, and make the infection extremely virulent, have been identified in new research published today.

Tioga Pharmaceuticals to utilize $18M equity funding for Phase 3 clinical trial of asimadoline

Tioga Pharmaceuticals, Inc. today announced the closing of an $18 million equity financing. Current investors Forward Ventures, New Leaf Venture Partners and BB Biotech Ventures were joined by new investor Genesys Capital Partners.

HealthAmerica expands social media platform through relationship with CaféWell

HealthAmerica announced today the expansion of its social networking community devoted solely to the health and well-being of its members through a relationship with CaféWell.

Allen S. Goldey, D.d.s., P.a. - Dental Clinic in Albion, ME